• ISRIB (trans-isomer): Unraveling Novel Pathways in Integr...

  2025-10-02

  Explore how ISRIB (trans-isomer), a leading integrated stress response inhibitor, is redefining ER stress research with unique insights into non-canonical ATF4 regulation and fibrotic disease intervention. Discover advanced mechanistic perspectives and translational opportunities distinct from existing literature.

• Phosbind Acrylamide: Redefining Phosphorylation Analysis ...

  2025-10-01

  Explore how Phosbind Acrylamide, a leading phosphate-binding reagent, enables antibody-free, high-resolution protein phosphorylation analysis—now applied to uncovering molecular mechanisms in spermatogenesis and signaling. Discover unique insights and advanced applications not covered in existing literature.

• EZ Cap™ Human PTEN mRNA (ψUTP): Enhancing Cancer Research...

  2025-09-30

  EZ Cap™ Human PTEN mRNA (ψUTP) stands at the forefront of in vitro transcribed mRNA technologies, providing robust mRNA stability and immune evasion for advanced cancer research. This guide details optimized workflows, real-world applications in overcoming therapeutic resistance, and practical troubleshooting, setting this reagent apart from conventional mRNA tools.

• Torin2: Precision mTOR Inhibition for Apoptosis Research

  2025-09-29

  Explore how Torin2, a highly selective mTOR inhibitor, advances cancer research through unprecedented mechanistic clarity of mTOR signaling pathway inhibition and apoptosis. This article offers a unique systems-level perspective, integrating novel insights from recent discoveries in regulated cell death.

• c-Myc Tag Peptide: Driving Next-Generation Cancer Biology...

  2025-09-28

  Discover how the c-Myc tag Peptide revolutionizes research in cancer biology through advanced immunoassay disruption, transcription factor regulation, and novel applications in cell signaling. Explore unique, in-depth insights into proto-oncogene c-Myc mechanisms and research reagent innovation.

• 3X (DYKDDDDK) Peptide: Enabling Next-Gen Multipass Membra...

  2025-09-27

  Explore how the 3X (DYKDDDDK) Peptide revolutionizes affinity purification and immunodetection of multipass membrane proteins. This deep dive reveals unique mechanisms of epitope tagging, advanced applications, and recent structural insights for cutting-edge protein research.

• Nonivamide: Precision TRPV1 Agonism for Advanced Cancer M...

  2025-09-26

  Explore Nonivamide, a potent capsaicin analog and TRPV1 receptor agonist, as a next-generation anti-proliferative agent for cancer research. This article uniquely dissects mitochondrial apoptosis pathways and in vivo tumor xenograft applications, offering insights beyond current literature.

• Anti Reverse Cap Analog (ARCA): Driving Precision in mRNA...

  2025-09-25

  Discover how Anti Reverse Cap Analog (ARCA), 3´-O-Me-m7G(5')ppp(5')G, revolutionizes synthetic mRNA capping for enhanced translation and stability. This in-depth analysis uniquely explores ARCA’s pivotal role in precise cellular reprogramming, advanced mRNA therapeutics, and the future of gene expression modulation.

• Sulfo-NHS-SS-Biotin Kit: Precision Mapping of Cell Surfac...

  2025-09-24

  Explore how the Sulfo-NHS-SS-Biotin Kit enables advanced, reversible biotin labeling with disulfide cleavage to dissect complex cell surface protein and glycoRNA domains. This article offers an in-depth, scientifically rigorous perspective on protein and antibody biotinylation for purification and interaction studies, expanding upon standard applications.

• Rucaparib (AG-014699): PARP1 Inhibition, Radiosensitizati...

  2025-09-23

  Explore the multifaceted role of Rucaparib (AG-014699, PF-01367338), a potent PARP1 inhibitor, in DNA damage response research—highlighting its radiosensitizer activity in PTEN-deficient and ETS-fusion-expressing cancer models and new perspectives on apoptotic signaling pathways.

• br Disclosure br Acknowledgments br Introduction Deeper unde

  2025-03-03

  

  Disclosure Acknowledgments Introduction Deeper understanding of the pathobiology of non-small cell lung cancer (NSCLC) has led to the development of small LY 379268 signaling that target genetic mutations known to play critical roles in the progression to metastatic disease. Mutations in ep

• DiscoveryProbe™ Natural Product Library Curcumin is able to

  2025-03-03

  

  Curcumin is able to upregulate the protein level of NGF through cannabinoid receptor CB1, where the activation of Akt pathway probably plays an important part in the CB1-mediated signal transmission [9,10]. This finding suggested that the protection of curcumin in spinal motor neurons of SNI rats is

• Gratifyingly compound also demonstrated improved physicochem

  2025-03-03

  

  Gratifyingly, compound also demonstrated improved physicochemical properties with significant improvement in aqueous solubility. Compound was sufficiently potent to determine its pharmacokinetic (PK) and pharmacodynamics (PD); data is summarized in . shows ADME characteristics for compound and

• br Conclusions br Introduction During

  2025-03-03

  

  Conclusions Introduction During numerous physiological processes, aldehydes are generated from a variety of endogenous and exogenous precursors including amino acids, carbohydrates, and lipids [1]. Most aldehydes are highly reactive and cytotoxic due to the strong electrophilic nature of the t

• By applying each external load to the

  2025-03-03

  

  By applying each external load to the G-actin molecule, and measuring the elongation of the molecule, we computed force-displacement curves. The force versus displacement curve can be used to evaluate the tensile stiffness of the G-actin from a linear regression analysis. Followed by statistical ana

16032 records 6/1069 page Previous Next First page 上5页 678910 下5页 Last page